Showing posts with label social cognition. Show all posts
Showing posts with label social cognition. Show all posts

Wednesday, 4 May 2011

Neuroethics: The Brain and Moral Beliefs

Jerome Grafman, Ph.D. presented the May 2011 Warren Frontiers in Neuroscience lecture “Brain Regions Supporting the Establishment of Human Beliefs” in Tulsa, Oklahoma.  I have typically summarized these lectures in a single Brain Posts blog posting.  But given the broad character of this presentation, I will break my summary into three parts based on the sections in the presentation: moral beliefs, religious beliefs and political beliefs.  Along with the lecture highlights, I will review relevant research manuscripts by Dr. Grafman and his research team.

A first step in studying concepts as abstract as morality is to define key components or factors within moral beliefs.  This is a common approach applicable to also religious and political beliefs.  Dr. Grafman prefers a more data driven approach to this task, rather than coming from a theoretical perspective.  The Moral Sentiment Task is a 98-item interview where subjects are given a scenario and asked to pick one of four responses that describes the feeling they would experience in that situation.  Using large population survey data, responses in this interview can be assigned to one of two sentiments:

Prosocial sentiments
  • embarrassment 
  • pity
  • guilt
Critical sentiments
  • anger
  • disgust
In a study with Jorge Moll and colleagues, Grafman examined a series of patients with frontotemporal dementia (FTD) using PET imaging and the Moral Sentiment Task.  Patients with FTD commonly exhibit impairment in social behaviors such as acting inappropriately (misjudge the social appropriateness of a behavior).  This socially inappropriate behavior commonly causes caregiver embarrassment and makes FTD often more difficult to manage than Alzheimer’s dementia.  Since the frontal lobe is felt to contribute to moral beliefs and judgment, a disease variably affecting the frontal lobe is likely to provide information about the effect of deficits in specific regions.

Patients with FTD were recruited for a study of the relationship between hypoactivation of specific brain regions with impairment in making accurate choices in the Moral Sentiment test.  As expected FTD, patients showed widespread decreased frontal lobe glucose utilization compared to controls.  In a correlational analysis, the following results were noted:
  • Decreased glucose utilization in the medial frontopolar cortex correlated with reduced prosocial sentiment
  • Decreased glucose utilization in the septum also correlated with impaired prosocial sentiment
  • Decreased glucose utilization in the dorsal medial prefrontal cortex and the amygdala correlated with reduced critical sentiment scores

In a review in the Annual Review of Neuroscience, Forbes and Grafman summarize the role of the prefrontal cortex in social cognition and moral judgment.  They note that there is significant overlap between processes involved in social cognition and moral judgment.  Social cognition has been described as the encoding, storage, retrieval and processing in the brain of information related to other members of the species. 

Elements of social cognition function can be implicit processes (occurring rapidly with little cognitive effort and outside conscious awareness) or explicit processes (deliberate, cognitively taxing and consciously accessible).  Implicit social cognition appears to have evolved earlier and is linked to the posterior cortex and subcortical regions.  Explicit social cognition evolved later and relies heavily on the prefrontal cortex (PFC). 

The prefrontal cortex appears to be a key area involved in making moral judgments.  Using fMRI brain PFC regions activate with processing a moral challenge.  Interestingly, the specific region of PFC involved in making a decision appears to be separate for making a decision on an impersonal moral dilemma (whether to flip a trolley track switch that will save five lives but lead to the death of one other person) or a personal moral dilemma (whether to smother your own crying baby if doing so would being detected by oppositional soldiers who will kill you and many other individuals).

Forbes and Grafman note in the conclusion of their review that “social interactions and judgments of humans have been based on evolutionary pressures and environmental and social contingencies”.  This evolution is continuing and they wonder if more impersonal world of advances such as Facebook and text messaging at a young age might drive the brain systems towards more “immediate results and gratification”.  Nevertheless, the emerging field of social neuroscience is likely to play a key role in better understanding neuroanatomical, genetic and environmental influences that effect our social development and the moral judgment we make.


Screen shot of prefrontal cortex from 3D Brain by Yates Photography.

In the next post, I will summarize research related to the brain and religious beliefs.  Dr. Grafman’s proposes an answer to the question “Is there a God spot in the brain?”

Moll J, Zahn R, de Oliveira-Souza R, Bramati IE, Krueger F, Tura B, Cavanagh AL, & Grafman J (2011). Impairment of prosocial sentiments is associated with frontopolar and septal damage in frontotemporal dementia. NeuroImage, 54 (2), 1735-42 PMID: 20728544


Forbes, C., & Grafman, J. (2010). The Role of the Human Prefrontal Cortex in Social Cognition and Moral Judgment Annual Review of Neuroscience, 33 (1), 299-324 DOI: 10.1146/annurev-neuro-060909-153230

Wednesday, 13 April 2011

Ecstasy Acute Effects on Social Cognition


MDMA (Ecstasy) Chemical Structure

Anecdotal reports suggest that some users of ecstasy (3,4-methlenedioxymethamphetamine-MDMA) experience increased feelings of empathy and are more social while under influence of the drug.  Such effects may contribute to the timing and frequency of ecstasy use and may also contribute to risk of abuse or dependence.  Understanding this phenomenon in more detail might provide clinicians with better strategies to reduce use and the associated complications of ecstasy use.

Studying acute effects of illicit drugs is difficult under natural conditions.  Users of ecstasy commonly also use alcohol, nictoine and other illicit drugs in the context of ecstasy use.  Isolating psychological effects of one agent in this type of environment is difficult if not impossible.  One alternative is to admiinster ecstasy in a laboratory setting with subjects blind to whether ecstasy or placebo is being administered.  However, this approach poses significant ethical challenges.  One approach, is to limit human study in the lab to those who have previously use ecstasy and intend to continue using.  Although imperfect, this approach limits risk of exposing ecstasy naive individuals to an illicit drug that may have reinforcing effects and increase risk of future drug use.

Chemical Structure of Methamphetamine
A study in Biological Psychiatry took this approach when over four sessions, healthy ecstasy using volunteers received either a low or high dose of MDMA, a dose of methamphetamine (METH) or placebo.  MDMA and methamphetamine share chemical (see chemical structures), pharmacological as well as psychological features.  Methamphetamine is typically considered a compound that increases CNS dopamine and norepinephrine while MDMA is felt to also increase CNS serotonin.   Ratings on a series of psychometric measures were obtained over a period of six hours after drug administration.  Visual analog scales (VAS) rated subjective feelings in a variety of domains: stimulated, bored, sedated, anxious, insightful, nauseated, loving, dizzy, sociable, confused, lonely, elated, playful, blank and restless.  Additionally, the rated themselves on the 72-item Profile of Mood States (POMS).  Subjects also completed a facial affect recognition task where they were asked to identify four facial emotions: anger, fear, happiness, sadness.

Here is a summary of the study findings for active agents compared to placebo:
MDMA (high dose) increased subjective VAS ratings of feeling "loving" and "friendly"
MDMA (low dose) increased subjective VAS ratings of "lonely"
MDMA (high dose) and METH increased VAS ratings of "playful"
METH alone increased VAS ratings of "sociability"
MDMA (high dose) reduced the accuracy of recognizing angry faces

So there is some support in this study for the anecdotal reports of increased prosocial cognition with MDMA.  The authors note their findings suggest MDMA increases social approach (sociability) rather thanThe authors note the study supports the possibility that increased social behavior with MDMA might be due to a reduced sensitivity to negative emotions of others rather than increasing recognition of positive emotions in others.  There also might be danger with this effect as social risk taking might increase potential for adverse consequences (connecting with someone you would be unlikely to connect with when not under the influence of MDMA).

Chemical structures of MDMA and methamphetamine from Wikipedia Creative Commons authored by Harbin.

Bedi G, Hyman D, & de Wit H (2010). Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological psychiatry, 68 (12), 1134-40 PMID: 20947066